Martin H. Steinberg

Active 1975–2025

Also published as
MARTIN H. STEINBERG
106
Papers
27,249
Citations
84
h-index
104
i10-index

Citations

Citations per year for Martin H. Steinberg1976: 1 citations1977: 1 citations1981: 6 citations1983: 1 citations1984: 14 citations1985: 12 citations1986: 7 citations1987: 10 citations1988: 7 citations1989: 6 citations1990: 8 citations1991: 12 citations1992: 4 citations1993: 10 citations1994: 4 citations1995: 9 citations1996: 17 citations1997: 24 citations1998: 37 citations1999: 40 citations2000: 65 citations2001: 69 citations2002: 90 citations2003: 103 citations2004: 119 citations2005: 160 citations2006: 163 citations2007: 171 citations2008: 192 citations2009: 190 citations2010: 258 citations2011: 199 citations2012: 215 citations2013: 203 citations2014: 163 citations2015: 180 citations2016: 197 citations2017: 180 citations2018: 159 citations2019: 596 citations2020: 638 citations2021: 609 citations2022: 544 citations2023: 362 citations2024: 698 citations2025: 309 citations2026: 16 citations1978–1980: no citations, so these years are not shown1982: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,747 citing papers, 37.2% of this breakdownUnited Kingdom: 560 citing papers, 7.6% of this breakdownChina: 330 citing papers, 4.5% of this breakdownItaly: 309 citing papers, 4.2% of this breakdownCanada: 302 citing papers, 4.1% of this breakdownFrance: 299 citing papers, 4.1% of this breakdownGermany: 240 citing papers, 3.3% of this breakdownNetherlands: 186 citing papers, 2.5% of this breakdownAustralia: 169 citing papers, 2.3% of this breakdownBrazil: 144 citing papers, 1.9% of this breakdownIndia: 127 citing papers, 1.7% of this breakdownSwitzerland: 118 citing papers, 1.6% of this breakdown
0%37.2%Other 25%

Fields

  • Medicine66.7%
  • Biochemistry, Genetics and Molecular Biology22.7%
  • Neuroscience2.6%
  • Health Professions1.6%
  • Immunology and Microbiology1.5%
  • Computer Science1%
  • Other3.9%

Topics

  • Hemoglobinopathies and Related Disorders13.9%
  • Iron Metabolism and Disorders7%
  • Dementia and Cognitive Impairment Research5.6%
  • CRISPR and Genetic Engineering4.3%
  • Blood groups and transfusion3.7%
  • Erythrocyte Function and Pathophysiology2.6%
  • Other62.9%

Coauthors

All papers

Open in search
  1. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 1,856

  2. Exagamglogene Autotemcel for Severe Sickle Cell Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 cited by 380

  3. Mortality In Sickle Cell Disease - Life Expectancy and Risk Factors for Early Death

    Authors: , , , , , , - New England Journal of Medicine 1994 cited by 3,340

  4. Intravascular hemolysis and the pathophysiology of sickle cell disease

    Authors: , , - Journal of Clinical Investigation 2017 cited by 711

  5. Neuropsychiatric Symptoms as Predictors of Progression to Severe Alzheimer’s Dementia and Death: The Cache County Dementia Progression Study

    Authors: , , , , , , - American Journal of Psychiatry 2015 cited by 413

  6. Sickle Cell Disease.

    Authors: , , - New England Journal of Medicine 2016 cited by 1,316

  7. Fetal hemoglobin in sickle cell anemia

    Authors: , , , , , , , - Blood 2011 cited by 543

  8. Point and 5‐year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study

    Authors: , , , , , , , , - International Journal of Geriatric Psychiatry 2007 cited by 743

  9. Fetal hemoglobin in sickle cell anemia

    Authors: - Blood 2020 cited by 128

  10. Fetal hemoglobin in sickle cell anemia: a glass half full?

    Authors: , , , , - Blood 2013 cited by 260

  11. Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2003 cited by 899

  12. Exagamglogene Autotemcel for Severe Sickle Cell Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2023 cited by 33

  13. The risks and benefits of long‐term use of hydroxyurea in sickle cell anemia: A 17.5 year follow‐up

    Authors: , , , , , , , , , , - American Journal of Hematology 2010 cited by 480

  14. Hormone therapy and Alzheimer disease dementia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carl F. Pieper, Brenda L. Plassman, Peter V. Rabins, Pritham Raj, Ingmar Skoog, David C. Steffens, Martin H. Steinberg, Marty Toohill, Leslie Toone, Jeannette J. Townsend, Michael Williams, Bonita W. Wyse - Neurology 2012 cited by 264

  15. Neuropsychiatric Symptoms as Risk Factors for Progression From CIND to Dementia: The Cache County Study

    Authors: , , , , , , , , - American Journal of Geriatric Psychiatry 2013 cited by 170

  16. Safety and Efficacy of CTX001 in Patients with Transfusion-Dependent β-Thalassemia and Sickle Cell Disease: Early Results from the Climb THAL-111 and Climb SCD-121 Studies of Autologous CRISPR-CAS9-Modified CD34+ Hematopoietic Stem and Progenitor Cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2020 cited by 51

  17. Genetic Signatures of Exceptional Longevity in Humans

    Authors: , , , , , , , , , , , , , , , - PLoS ONE 2012 cited by 465

  18. Treating Depression in Alzheimer Disease

    Authors: , , , , , , , , , , - Archives of General Psychiatry 2003 cited by 392

  19. Genetic modifiers of sickle cell disease

    Authors: , - American Journal of Hematology 2012 cited by 303

  20. Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin

    Authors: , , , , , , , - British Journal of Haematology 2011 cited by 135

  21. Fetal Hemoglobin in Sickle Hemoglobinopathies: High HbF Genotypes and Phenotypes

    Authors: - Journal of Clinical Medicine 2020 cited by 74

  22. Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes

    Authors: , , - Blood Reviews 2006 cited by 847

  23. Sickle Cell Anemia, the First Molecular Disease: Overview of Molecular Etiology, Pathophysiology, and Therapeutic Approaches

    Authors: - The Scientific World JOURNAL 2008 cited by 285

  24. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms

    Authors: , , , , , , , , , , , , , , , - Nature 2004 cited by 418